Cartesian Growth Ii (RENE) Annual Balance Sheets

Annual · GAAP · USD millions
Access RENE quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Cartesian Growth Ii's financial stability and long-term positioning.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent0.16
Cash & Short-term Investments0.00
Prepaid Expense, Current AS0.20
Total Current Assets0.36
Other Assets, Noncurrent37.91
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Cash And Marketable Securities Held In Trust Account-
Total Assets38.28
Liabilities
Accrued Liabilities, Current AC1.53
Notes Payable, Current NO4.20
Other Liabilities, Current0.00
Total Current Liabilities5.73
Long-term debt5.00
Total Long-term Debt5.00
Other liabilities, Noncurrent15.97
Accrued Offering Costs-
Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares4.47
Total Liabilities26.71
Stockholders' Equity
Common Stock Value-
Ordinary Shares Subject To Possible Redemption Value-
Common Stock Value0.00
Retained Earnings / Accumulated Deficit-26.34
Other Equity-37.91
Common Stockholder's Equity-64.26
Non-controlling interests & other37.91
Total Stockholder's Equity-26.34
Liabilities & Stockholder's Equity38.28
4 historic quarters locked

Sign in to unlock the full Cartesian Growth Ii balance sheet history.

About Cartesian Growth Corp Ii Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-037936

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.